Canada Life
BSX.PRA

Canada Life’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Canada Life’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$631K Sell
2022
Q4 		$1.08M Buy
2022
Q3 		$920K Buy
2022
Q2 		$780K Hold
2022
Q1 		$907K Hold
2021
Q4 		$880K Buy
2020
Q4 		– Sell
2020
Q3 		$278K Hold
2020
Q2 		$261K Buy